Michael Yee
Allan W. Wolkoff
<p><span>Dr. Allan Wolkoff's interest in research was sparked when he worked in a biochemistry lab to help pay college bills. He began his medical studies at Dartmouth Medical College and transferred to the Albert Einstein College of Medicine where he obtained his M.D. degree. With the exception of a two year period when he was Clinical Associate in Gastroenterology-Hepatology in the Digestive Disease Branch, National Institute of Arthritis, Metabolism and Digestive Disease, he has remained at Albert Einstein. His early mentor, Irwin M. Arias, M.D. of the National Institutes of Health said of Wolkoff’s work, “He built an exemplary global reputation in hepatology research, education, training and scholarship. A major participant in the creation of the Marion Bessin Liver Research Center at Albert Einstein, Dr. Wolkoff has taken advantage of the strong, interactive basic science departments and is a leader in bridging understanding of hepatocyte biology with the pathogenesis of acquired and inheritable liver diseases.” </span></p>
<p><span>Dr. Wolkoff is a pioneer in the combining of disciplines that inform basic understanding of hepatocyte function and relation to disease and is recognized worldwide for providing new windows into physiology and pathophysiology. </span><span>He has had articles published in over 100 peer-reviewed publications, given many invited lectures and has had continuous NIH-supported research. In addition, he has served on advisory committees of several NIH-supported liver research centers. In 2006, he was presented the AASLD Distinguished Service Award. In 2012, he received the <span>highly prestigious 2012 Distinguished Scientific Achievement Award from the American Liver Foundation.</span></span></p>
Diseases of the liver and biliary tract including chronic liver disease, fatty liver disease, hepatitis, inheritable disorders of the liver, drug toxicity, and unexplained jaundice.<quillbot-extension-portal></quillbot-extension-portal>
Research interests include the mechanism by which the liver removes drugs and other compounds from the circulation and how its dysfunction may lead to drug toxicity.<quillbot-extension-portal></quillbot-extension-portal>
<p>Allan W. Wolkoff, MD, is Chief, Hepatology, Herman Lopata Chair in Liver Disease Research and Professor, Medicine and Developmental & Molecular Biology at Montefiore Einstein. His clinical focus centers on diseases of the liver and biliary tract, including chronic liver disease, fatty liver disease, hepatitis, inheritable disorders of the liver, drug toxicity and unexplained jaundice.</p><p>Dr. Wolkoff began his medical studies at Dartmouth Medical College and transferred to Einstein, where he earned his Doctor of Medicine in 1972. He completed an internship at Bronx Municipal Hospital Center in 1973 before becoming an Assistant Resident in Medicine until 1974. Following this, Dr. Wolkoff became a Clinical Associate in Gastroenterology-Hepatology at the National Institutes of Health (NIH) until 1976.</p><p>A pioneer in combining disciplines that inform basic understanding of hepatocyte function and relation to disease, Dr. Wolkoff is recognized worldwide for providing new windows into physiology and pathophysiology. His research interests include the mechanism by which the liver removes drugs and other compounds from circulation and how its dysfunction may lead to drug toxicity. He has had articles published in over 100 peer-reviewed publications, given many invited lectures and has had continuous NIH-supported research.</p><p>Dr. Wolkoff has served on advisory committees of several NIH-supported liver research centers. In 2006, he was presented with the American Association for the Study of Liver Diseases (AASLD) Distinguished Service Award. In 2012, he received the highly prestigious Distinguished Scientific Achievement Award from the American Liver Foundation. He was named Physician of the Year by the Greater New York Division of the American Liver Foundation in 2015 and won the National Leadership Award from the American Liver Foundation in 2022.</p>
Yanhua Wang
<p><strong>Areas of Research</strong>: Primary research areas are focused on identifying distinctive immunologic and molecular genetic diagnostic and prognostic markers of hematologic neoplasms.</p>
<p><strong>Professional Interests:</strong> Pathological diagnosis of hematopoietic abnormalities, including mature and immature lymphoma/leukemia; myeloproliferative/dysplastic myeloid neoplasms, plasma cell proliferative disorder and other hematological related abnormalities using flow cytometry, immunohistochemistry, cytogentic/FISH and molecular diagnostic tools.</p>
<p> </p>
<p><strong>Selected Recent Publications:</strong></p>
<p><strong> 1.</strong><strong> </strong><strong>Yanghua Wang<sup>1</sup></strong>, Adam Gersten<sup>1</sup>, Susana Moleirinho<sup>2,3</sup>, Frank J. Gunn-Moore<sup>2</sup>, Paul A. Reynolds<sup>3</sup>, Michael B. Prystowsky<sup>1 </sup> Fibroblasts in Head Neck Squamous Cell Carcinoma Associated with Peri-neural Invasion Have High Level Nuclear Yap Expression Academic Pathology, 2015<strong>2. </strong></p>
<p><strong>2.</strong> Jose G.M. Arango, Shlomit Goldberg-Stein, <strong>Yanhua Wang</strong> Extranodal Rosai-Dorfman disease: Clinico-pathologic series of thirteen cases and review of the literature American Journal of Clinical Pathology, 2016; 0:1-11</p>
<p><strong>3. </strong>Monica Zell,*, Amer Assal,*, Olga Derman, Noah Kornblum, Ramakrishna Battini, <strong>Yanhua Wang</strong>, Deepa M. Narasimhulu, Ioannis Mantzaris, Aditi Shastri, Amit Verma, Hilda Ye, IraBraunschweig, Murali Janakiram Adult T-Cell leukemia/lymphoma in the Caribbean cohort is adistinct clinical entity with dismal response to conventional chemotherapy Oncotarget, June 2016<strong> <strong>DOI: 10.18632/oncotarget.10223</strong></strong></p>
<p><strong>4. </strong>Goel S, Hall J, Pradhan K, Hirsch C, Przychodzen B, Shastri A, Mantzaris I, Janakiram M, Battini R, Kornblum N, Derman O, Gritsman K, Al-Hafidh J, <strong>Wang Y</strong>, Halmos B, Steidl U, Maciejewski JP, Braunschweig I, Verma A. High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort. Leukemia. 2016 Apr 29. doi: 10.1038/leu.2016.74. [Epub ahead of print]</p>
<p><strong>5. </strong>Monica Zell, Amer Assal, Olga Derman, Noah Kornblum, Ramakrishna Battini,<strong> Yanhua Wang</strong>, Deepa M. Narasimhulu, Ioannis Mantzaris, Aditi Shastri, Amit Verma, Hilda Ye, Ira Braunschweig, Murali Janakiram Adult T-Cell leukemia/lymphoma in the Caribbean cohort is a distinct clinical entity with dismal response to conventional chemotherapy. Oncotarget, Advance Publications 2016</p>
<p><strong>6. </strong> <strong>Yanhua Wang</strong>, Samer Khader, Yonatan Mehlman, Yungtai Lo, Joseph Albanese, Howard Ratech Loss of αII and βIII Spectrin Isoforms in Body Fluids is Associated with Metastasis. Advances in Cytology & Pathology, Volume 2 Issue 1 – 2017</p>
<p><strong>7. </strong>Etan Marks, Yang Shi, <strong>Yanhua Wang</strong> CD117 (KIT) Is A Useful Marker in The Diagnosis of Plasmablastic Plasma Cell Myeloma, Histopathology, 2017, <strong>DOI:</strong><strong> </strong>10.1111/his.13196</p>
<p><strong>8. </strong>Murali Janakiram , Amit Verma, <strong>Yanhua Wang</strong>, Anjali Budhathoki, Jaime Suarez Londono, Irina Murakhovskaya, Ira Braunschweig & Caterina P.Minniti Accelerated leukemic transformation after haploidentical transplantation for hydroxyurea-treated sickle cell disease, Leukemia & Lymphoma, DOI: 10.1080/10428194.2017.1324158</p>
<p><strong>9. </strong>Zhonghua Li, M.D., Ph.D., John G. Pizzolo, B.S., <strong>Yanhua Wang</strong>, M.D., Ph.D.Utility of Cytocentrifugation Slides in the Flow Cytometry Laboratory: a Single Institution experience, Clinical Pathology Diangosis, Journal of Hematopathology, online, 2017</p>
<p><strong>10. </strong>Michael J. Licata, MD<sup>1</sup>, Murali Janakiram, MD<sup>2</sup>, Yanan Fang, MD<sup>1</sup>, Urvi A. Shah, MD<sup>2</sup>, Amit Verma, MD<sup>2</sup> and <strong>Yanhua Wang</strong>, MD Diagnostic Challenges of Western Adult T-Cell Leukemia/Lymphoma with Unusual Clinical Presentation - Clinical, Histological and Immunophenotypic Analysis, Leukemia & Lymphoma, 2018 VOL. 59, NO. 5, 1188–1194 https://doi.org/10.1080/10428194.2017.1365862</p>
<p><strong>11. </strong>Evan Himchak, Etan Marks, Yang Shi, <strong>Yanhua Wang</strong>, Did I miss one? Discovering Hidden Co-existing Hematological with Non-Hematological Malignancies, A Single Institutional Review of 100 Collision Tumors, <a title="International journal of surgical pathology." href="https://www.ncbi.nlm.nih.gov/pubmed/29320898">Int J Surg Pathol.</a> 2018 Jan 1:1066896917752862. doi: 10.1177/1066896917752862. [Epub ahead of print]</p>
<p><strong>12. </strong>Jesus Anampa, Tamanna Haque, Irina Murakhovskaya, <strong>Yanhua Wang</strong>, Kimo Bachiashvili, Cristian Papazoglu, Kith Pradhan, Ulrich G. Steidl, Joseph A. Sparano, Amit Verma<sup> </sup>Macrocytosis And Dysplastic Anemia Is Associated With The Cyclin-Dependent Kinase 4/6 Inhibitor Palbociclib In Metastatic Breast Cancer, Haematologica , Published Ahead of Print on November 30, 2017, as doi:10.3324/haematol.2017.181941</p>
<p><strong>13. </strong>Shaomin Hu, James Szymanski, Zeina Khairy, Yungtai Lo, <strong>Yanhua Wang</strong> Breast pathology and mammography BI-RADS category correlation study – A single institute experience Annals of Diagnostic Pathology 35 (2018) 11-15</p>
<p><strong>14. </strong>Shah UA, Chung EY, Giricz O, Pradhan K, Kataoka K, Gordon-Mitchell S, Bhagat TD, Mai Y, Wei Y, Ishida E, Choudhary GS, Joseph A, Rice R, Gitego N, Parrish C, Bartenstein M, Goel S, Mantzaris I, Shastri A, Derman O, Binder A, Gritsman K, Kornblum N, Braunschweig I, Bhagat C, Hall J, Graber A, Ratner L, <strong>Wang Y, </strong>Ogawa S, Verma A, Ye BH, Janakiram M. North American ATLL has a distinct mutational and transcriptional profile and responds to epigenetic therapies. Blood. 2018 Oct 4;132(14):1507-1518. doi: 10.1182/blood-2018-01-824607. Epub 2018 Aug 13.</p>
<h1> </h1>
<p> </p>
<p> </p>
<p> </p>
<p> </p>
Preeti Viswanathan
Dr. Viswanathan received her Medical training at Kempegowda Institute of Medical Sciences in Bangalore, India. She then completed her Pediatric Residency at Miami Children?s Hospital and her fellowship at The Children?s Hospital at Montefiore. She has presented her research at national meetings and has received the Best Research Award at Pediatric Research Day Children?s Hospital at Montefiore 2011.
Victoria Vapnyar
Clara Y. Tow
<p>Dr. Tow is a transplant hepatologist and Assistant Professor of Medicine at Montefiore Medical Center and Albert Einstein College of Medicine. She serves as the Clinical Site Director of Hepatology at the Weiler Division of MMC, Associate Program Director of the Gastroenterology & Liver Diseases Fellowship Program, and the Co-Director of the AECOM Gastroenterology & Hepatology Systems Course.</p>
<p>Dr. Tow holds a B.A. in Biological Sciences from Cornell University College of Arts and Sciences and graduated Phi Beta Kappa and Magna Cum Laude for her work in developmental research. While attending Weill Cornell Medical College, she developed her passion for transplant medicine and was awarded Alpha Omega Alpha and Honors in Research for her characterization of mitochondrial injury during ischemia-reperfusion injury. Dr. Tow completed her internship and residency in Internal Medicine at New York Presbyterian Hospital - Weill Cornell Medical Center, where she served as an education resident, and fellowship in Gastroenterology and Liver Diseases at Montefiore Medical Center. Subsequently she pursued her advanced fellowship training in Transplant Hepatology at New York Presbyterian Hospital – Columbia University Medical Center.</p>
<p>Dr. Tow has been at Montefiore/Einstein since 2018, where she specializes on the complications of advanced liver diseases, liver cancer, and liver transplant. She believes every patient is an integral part of the Montefiore family and that patient knowledge is power. Her goal is to provide patients and their families the best medical care that is embedded in kindness, dignity, and respect. </p>
Dr. Tow specializes in the treatment of complications of advanced liver diseases, liver cancer, and liver transplant. She believes every patient is an integral part of the Montefiore Einstein family and that patient knowledge is power. Her goal is to provide patients and their families with the best medical care embedded in kindness, dignity, and respect.<quillbot-extension-portal></quillbot-extension-portal>
Dr. Tow’s research focuses on social determinants of health and outcomes related to liver transplantation and the care of advanced liver disease. She has spoken at invited lectures nationally and internationally, and her work has been published in many peer-reviewed journals, books, chapters, review articles, and abstracts.<quillbot-extension-portal></quillbot-extension-portal>
<p>Clara Y. Tow, MD, is Clinical Site Director, Hepatology, Associate Program Director, Gastroenterology & Liver Diseases Fellowship Program, Co-Course Director, Gastroenterology & Hepatology Systems Course and Assistant Professor, Medicine at Montefiore Einstein. Dr. Tow specializes in the treatment of complications of advanced liver diseases, liver cancer and liver transplant. She believes every patient is an integral part of the Montefiore Einstein family and that patient knowledge is power. Her goal is to provide patients and their families with the best medical care embedded in kindness, dignity and respect.</p><p>After obtaining her Bachelor of Arts in biological sciences from Cornell University College of Arts and Sciences, Dr. Tow earned her Doctor of Medicine from Weill Cornell Medical College. She then completed her internship and residency in internal medicine at NewYork-Presbyterian Hospital, Weill Cornell Medical Center. Following this, she completed a gastroenterology and liver diseases fellowship at Montefiore Medical Center before pursuing her advanced fellowship training in transplant hepatology at NewYork-Presbyterian Hospital.</p><p>Dr. Tow’s research focuses on social determinants of health and outcomes related to liver transplantation and the care of advanced liver disease. She has spoken at invited lectures nationally and internationally, and her work has been published in many peer-reviewed journals, books, chapters, review articles and abstracts.</p><p>Dr. Tow is board certified by the American Board of Internal Medicine in transplant hepatology, gastroenterology and internal medicine. She is a member of the American Association for the Study of Liver Diseases (AASLD), the American Society of Transplantation (AST) and the European Association for the Study of the Liver (EASL). She is also a member of the Empire Liver Foundation and a Medical Advisor for the American Liver Foundation. In 2014, Dr. Tow won the Erica C. Jones & Naina Sinha-Gregory Prize in Medicine.</p>
Aaron Zev Tokayer
<p>Dr. Tokayer received his B.A. in from Yeshiva College and his M.D. from Albert Einstein College of Medicine of Yeshiva University. He completed an internship and residency at the Bronx Municipal Hospital Center and GI and Hepatology fellowship at Johns Hopkins Medical Center. He received an MHS degree in Clinical Epidemiology from Johns Hopkins School of Public Health. Dr. Tokayer then joined the Montefiore GI Faculty in 1992. He has been involved in the spectrum of clinical patient care, endoscopic interventions and teaching in the GI fellowship program. His areas of interest include clinical practice, patient care and education, endoscopic procedures and interventions, functional GI and motility disorders. He is Director of the GI Motility Lab where studies such as Esophageal Manometry, Esophageal Acid Monitoring and Impedance Testing, Ano-rectal Manometry and Defecatory Testing, Hydrogen Breath Testing for Bacterial overgrowth and Carbohydrate Maldigestion , and studies of gastric and intestinal transit. He works closely with colleagues of the Department of Radiology and Nuclear Medicine as well as the Department of Surgery in diagnosing and treating GI motility disorders.</p>
Asli S. Sucu
Martina Stehlikova
<p>In-patient internal medicine with a special interest in hematology. Anemia, thrombocytopenia and coagulopathy in hospitalised patients.</p>